Feasibility Study of Adaptive Radiotherapy for the Treatment of Locally-Advanced Anal Squamous Cell Carcinoma
Sponsor: |
Varian |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAU0074 |
U.S. Govt. ID: |
NCT05838391 |
Contact: |
Christina Chesnakov: / cc4047@cumc.columbia.edu |
The purpose of this study is to find out if performing adaptive planning during the treatment anal cancer will decrease the dose of radiation to normal organs and decrease the side effects. In this study, subjects will have a daily adjustment (adaptation) of their radiation plan as the tumor changes during the radiation treatment. The radiation will be given as part the standard of care treatment with chemotherapy, known as chemo-RT (CRT).
Investigator
Lisa Kachnic, MD, FASTRO
Have you been diagnosed with invasive anal cancer? |
Yes |
No |